{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:47:58Z","timestamp":1791942478588,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Neurosurg Jl"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study analyzed the safety and efficacy of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms by examining stent-vessel apposition, operative complications, embolization outcomes, and clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed the medical records of patients with wide-necked intracranial aneurysms who underwent Enterprise 2 stent-assisted coiling in our hospital from November 2018 to October 2019. Intraoperative VasoCT was performed immediately after stent release in a continuous cohort of patients to observe stent-vessel apposition. Patient demographic, clinical, and imaging data were recorded and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 106 wide-necked aneurysms in 106 patients were treated. Stent release was successful in all patients. Twenty-one patients were enrolled consecutively for VasoCT scanning, and incomplete stent apposition was observed in 5 (23.8%). Perioperative complications occurred in 10 patients (9.4%): cerebral infarction in 6, intraoperative coil prolapse in 1, puncture site pseudoaneurysm in 1, deep vein thrombosis at multiple sites in 1, and transient brainstem mass effect in 1. Among the 95 aneurysms with angiographic follow-up, embolization was satisfactory (Raymond\u2013Roy classifications I and II) in 89 (93.7%). Hyperlipidemia was an independent risk factor for incomplete aneurysm occlusion. At the last clinical follow-up, seven patients had a poor clinical outcome (modified Rankin Scale score\u2009\u2265\u20093). Independent risk factors for poor outcomes were preoperative subarachnoid hemorrhage at presentation and cerebral infarction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Enterprise 2 stent-assisted coiling for treatment of wide-necked intracranial aneurysms showed good safety and efficacy; however, incomplete stent apposition can still occur in vessels with a large curvature. Preoperative subarachnoid hemorrhage at presentation and cerebral infarction are the main reasons for poor clinical outcomes after stent-assisted coil embolization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41016-022-00298-w","type":"journal-article","created":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T02:03:38Z","timestamp":1664676218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms"],"prefix":"10.1186","volume":"8","author":[{"given":"Yangyang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"key":"298_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4103\/0976-3147.182767","volume":"7","author":"T Nanba","year":"2016","unstructured":"Nanba T, Kashimura H, Saura H, et al. Subarachnoid hemorrhage due to ruptured intracranial aneurysm following posterior reversible encephalopathy syndrome. J Neurosci Rural Pract. 2016;7:440\u20132.","journal-title":"J Neurosci Rural Pract"},{"key":"298_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5469\/neuroint.2011.6.2.53","volume":"6","author":"BM Kim","year":"2011","unstructured":"Kim BM, Kim DJ, Kim DI. Stent application for the treatment of cerebral aneurysms. Neurointervention. 2011;6:53\u201370.","journal-title":"Neurointervention"},{"key":"298_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.wneu.2016.06.014","volume":"93","author":"MT Feng","year":"2016","unstructured":"Feng MT, Wen WL, Feng ZZ, et al. Endovascular embolization of intracranial aneurysms: to use stent(s) or not? Systematic review and meta-analysis. World Neurosurg. 2016;93:271\u20138.","journal-title":"World Neurosurg"},{"key":"298_CR4","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jocn.2012.11.010","volume":"20","author":"SK Hwang","year":"2013","unstructured":"Hwang SK, Hwang G, Bang JS, et al. Endovascular Enterprise stent-assisted coil embolization for wide-necked unruptured intracranial aneurysms. J Clin Neurosci. 2013;20:1276\u20139.","journal-title":"J Clin Neurosci"},{"key":"298_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/ajns.AJNS_284_19","volume":"15","author":"RK Goyal","year":"2020","unstructured":"Goyal RK, Kato Y, Kawase T, et al. Comparative outcome analysis of enterprise and neuroform stent-assisted coiling of cerebral aneurysms: a review of the literature. Asian J Neurosurg. 2020;15:4\u20139.","journal-title":"Asian J Neurosurg"},{"key":"298_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2008.7.JNS08322","volume":"110","author":"J Mocco","year":"2009","unstructured":"Mocco J, Snyder KV, Albuquerque FC, et al. Treatment of intracranial aneurysms with the Enterprise stent: a multicenter registry. J Neurosurg. 2009;110:35\u20139.","journal-title":"J Neurosurg"},{"key":"298_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00062-016-0545-9","volume":"28","author":"C Herweh","year":"2018","unstructured":"Herweh C, Nagel S, Pfaff J, et al. First experiences with the new Enterprise2(R) stent. Clin Neuroradiol. 2018;28:201\u20137.","journal-title":"Clin Neuroradiol"},{"key":"298_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.wneu.2018.03.220","volume":"115","author":"JD Hughes","year":"2018","unstructured":"Hughes JD, Bond KM, Mekary RA, et al. Estimating the global incidence of aneurysmal subarachnoid hemorrhage: a systematic review for central nervous system vascular lesions and meta-analysis of ruptured aneurysms. World Neurosurg. 2018;115:430-447.e7.","journal-title":"World Neurosurg"},{"key":"298_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/jscd.2002.130390","volume":"11","author":"A Molyneux","year":"2002","unstructured":"Molyneux A, Kerr R, International subarachnoid aneurysm trial collaborative group, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis. 2002;11:304\u201314.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"298_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3174\/ajnr.A1488","volume":"30","author":"RA Willinsky","year":"2009","unstructured":"Willinsky RA, Peltz J, da Costa L, et al. Clinical and angiographic follow-up of ruptured intracranial aneurysms treated with endovascular embolization. AJNR Am J Neuroradiol. 2009;30:1035\u201340.","journal-title":"AJNR Am J Neuroradiol"},{"key":"298_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3174\/ajnr.A4542","volume":"37","author":"RS Bechan","year":"2016","unstructured":"Bechan RS, Sprengers ME, Majoie CB, et al. Stent-assisted coil embolization of intracranial aneurysms: complications in acutely ruptured versus unruptured aneurysms. AJNR Am J Neuroradiol. 2016;37:502\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"298_CR12","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3174\/ajnr.A2584","volume":"32","author":"RS Heller","year":"2011","unstructured":"Heller RS, Malek AM. Parent vessel size and curvature strongly influence risk of incomplete stent apposition in enterprise intracranial aneurysm stent coiling. AJNR Am J Neuroradiol. 2011;32:1714\u201320.","journal-title":"AJNR Am J Neuroradiol"},{"key":"298_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00701-015-2666-3","volume":"158","author":"K Kono","year":"2016","unstructured":"Kono K, Terada T. In vitro experiments of vessel wall apposition between the Enterprise and Enterprise 2 stents for treatment of cerebral aneurysms. Acta Neurochir (Wien). 2016;158:241\u20135.","journal-title":"Acta Neurochir (Wien)"},{"key":"298_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/neurintsurg-2019-014966","volume":"12","author":"N Kato","year":"2020","unstructured":"Kato N, Yuki I, Ishibashi T, et al. Visualization of stent apposition after stent-assisted coiling of intracranial aneurysms using high resolution 3D fusion images acquired by C-arm CT. J Neurointerv Surg. 2020;12:192\u20136.","journal-title":"J Neurointerv Surg"},{"key":"298_CR15","doi-asserted-by":"publisher","first-page":"589689","DOI":"10.3389\/fneur.2020.589689","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen L, Zheng C, Wu J, et al. The Enterprise2 stent for endovascular treatment of intracranial aneurysms: short-term results from a single center experience. Front Neurol. 2020;11:589689.","journal-title":"Front Neurol"},{"key":"298_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1227\/NEU.0b013e318228490c","volume":"69","author":"J Mocco","year":"2011","unstructured":"Mocco J, Fargen KM, Albuquerque FC, et al. Delayed thrombosis or stenosis following enterprise-assisted stent-coiling: is it safe? Midterm results of the interstate collaboration of enterprise stent coiling. Neurosurgery. 2011;69:908\u201313 (discussion 913-4).","journal-title":"Neurosurgery"},{"key":"298_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/neurintsurg-2016-012400","volume":"9","author":"H Chihara","year":"2017","unstructured":"Chihara H, Ishii A, Kikuchi T, et al. Deployment technique that takes advantage of the characteristics of Enterprise VRD2: an in vitro study. J Neurointerv Surg. 2017;9:969\u201373.","journal-title":"J Neurointerv Surg"}],"container-title":["Chinese Neurosurgical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-022-00298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41016-022-00298-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-022-00298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T02:04:43Z","timestamp":1664676283000},"score":1,"resource":{"primary":{"URL":"https:\/\/cnjournal.biomedcentral.com\/articles\/10.1186\/s41016-022-00298-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1186\/s41016-022-00298-w","relation":{},"ISSN":["2057-4967"],"issn-type":[{"value":"2057-4967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]},"assertion":[{"value":"11 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves human participants and was approved by the Ethics Committee of Beijing Tiantan Hospital (QX2019-009\u201310). Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}